SG

Subramanian Ganesan

Active Director Director DIN 02013825
DIN 02013825 First appointment Feb 2009 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 5 historical roles
Total affiliations 9 Since Feb 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Subramanian Ganesan

Data last updated:

Subramanian Ganesan is a Director at Spire Labs India Private Limited (since 2014), Designated Partner at Rbc Healthcare Services Llp (since 2023) and Director at Senmag Therapeutics Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Healthcare, Life Sciences and Real Estate and Construction. Earlier, Subramanian Ganesan was a Director at Centralab Healthcare Services Private Limited (2011–2023) and Director at Amulyam Stocks And Investments Private Limited (2011–2019) and 3 more.

DIN 02013825
Primary Designation Director
Industry Healthcare
First Appointment 18 Feb 2009
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spire Labs India Private Limited U85195TZ2012PTC018650
Director06 Feb 20142012Active
Designated Partner12 Jul 20232022Active
Senmag Therapeutics Private Limited U85300TN2023PTC158116
Director06 Jan 20232023Active
Designated Partner11 Jan 20222021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20112011₹25.51 Cr (FY 2025)Active
Director09 Dec 20112011₹50,017 (FY 2017)Strike Off
Amulyam Commodities Private Limited U67100TN2012PTC083840
Director02 Jan 20122012Strike Off
Director17 Dec 20192019Strike Off
Managing Director18 Feb 20092009₹124 Cr (FY 2021)Dissolved Under Section 59(8)

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Subramanian Ganesan

Directorship timeline

Open interactive timeline →
Senmag Cell And Gene Therapy Private Limited
Spire Labs India Private Limited
Dr.Ganesan's Hitech Diagnostic Centre Private Limited
Senmag Therapeutics Private Limited
Premium access

Shareholding and investment profile for Subramanian Ganesan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subramanian Ganesan

Subramanian Ganesan currently holds 4 directorships: Spire Labs India Private Limited (Director, since 06 Feb 2014); Rbc Healthcare Services Llp (Designated Partner, since 12 Jul 2023); Senmag Therapeutics Private Limited (Director, since 06 Jan 2023); Vishwak Value Homes Llp (Designated Partner, since 11 Jan 2022).

Subramanian Ganesan was first appointed on 18 Feb 2009 as Managing Director at Dr.Ganesan's Hitech Diagnostic Centre Private Limited. The most recent appointment on record is 12 Jul 2023 at Rbc Healthcare Services Llp.

Subramanian Ganesan held 5 earlier board appointments: Centralab Healthcare Services Private Limited (Director, 29 Mar 2011 to 24 Jul 2023); Amulyam Stocks And Investments Private Limited (Director, 09 Dec 2011 to 30 Sep 2019); Amulyam Commodities Private Limited (Director, 02 Jan 2012 to 30 Sep 2019); Senmag Cell And Gene Therapy Private Limited (Director, from 17 Dec 2019); Dr.Ganesan's Hitech Diagnostic Centre Private Limited (Managing Director, from 18 Feb 2009).

The current boards of Subramanian Ganesan's companies include Ganesan Manimegalai (Spire Labs India Private Limited), Muthusamy Narayanan Sadasivam (Rbc Healthcare Services Llp), Senthil Ganesan (Rbc Healthcare Services Llp), Gaurav Bhandari (Vishwak Value Homes Llp), Mahalingam (Vishwak Value Homes Llp), Raju Ramaprabha (Vishwak Value Homes Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available